
Sign up to save your podcasts
Or


This week, Kate, Gary, Mark and Henry discuss treatments for osteoporosis in post-menopausal women, the effect of adding evolocumab to a statin - a reanalysis of the FOURIER trial, using mifepristone for painful adenomyosis, and real world data comparing 24-hour ambulatory BP with clinic readings.
By Mark Ebell4.7
9292 ratings
This week, Kate, Gary, Mark and Henry discuss treatments for osteoporosis in post-menopausal women, the effect of adding evolocumab to a statin - a reanalysis of the FOURIER trial, using mifepristone for painful adenomyosis, and real world data comparing 24-hour ambulatory BP with clinic readings.

135 Listeners

696 Listeners

495 Listeners

290 Listeners

298 Listeners

263 Listeners

3,338 Listeners

1,153 Listeners

195 Listeners

85 Listeners

511 Listeners

364 Listeners

248 Listeners

369 Listeners

314 Listeners